Although gynecological cancers, for instance, breast cancer and endometrial carcinomas, are stongly promoted by female hormones, the rate of hormone receptor expression is reported to be significantly less in uterine LMS than in normal uterine smooth muscle (USM). The gene discussed is NR4A1; the disease is female reproductive organ cancer.